Harold I. Feldman
Nephrology · 2002–2020
A researcher in the Science corpus: 12 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Nephrology — 108 citations into it
Whom Harold I. Feldman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Harold I. Feldman's perspective
Ordered by how strongly the researchers Harold I. Feldman trusts endorse each paper. Same corpus, a different order for every researcher.
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
- Prevalence of chronic kidney disease in the United States. (Journal of the American Medical Association (JAMA))
- Age affects outcomes in chronic kidney disease. (Journal of the American Society of Nephrology)
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
- Guidelines for investigating causality of sequence variants in human disease
- The support of human genetic evidence for approved drug indications (Nature Genetics)
- Worldwide access to treatment for end-stage kidney disease: a systematic review. (The Lancet)
- International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. (The Lancet)
Their papers
- Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) — 632 citations
- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017) — 787 citations
- KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. (2014) — 1,653 citations
- APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease (2013) — 721 citations
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C (2012) — 3,714 citations
- FGF23 induces left ventricular hypertrophy. (2011) — 1,899 citations
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease (2011) — 1,002 citations
- A New Equation to Estimate Glomerular Filtration Rate (2009) — 23,696 citations
- Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. (2008) — 1,010 citations
- Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. (2008) — 820 citations
- The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. (2003) — 595 citations
- The association between hepatitis C infection and survival after orthotopic liver transplantation. (2002) — 1,158 citations